APA (7th ed.) Citation

P, F., S, S., G, V., DA, S., N, J., N, B., . . . S, S. (2023). Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 190, 94. https://doi.org/10.1016/j.ejpb.2023.07.008

Chicago Style (17th ed.) Citation

P, Famta, et al. "Quality by Design Endorsed Fabrication of Ibrutinib-loaded Human Serum Albumin Nanoparticles for the Management of Leukemia." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V 190 (2023): 94. https://doi.org/10.1016/j.ejpb.2023.07.008.

MLA (9th ed.) Citation

P, Famta, et al. "Quality by Design Endorsed Fabrication of Ibrutinib-loaded Human Serum Albumin Nanoparticles for the Management of Leukemia." European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V, vol. 190, 2023, p. 94, https://doi.org/10.1016/j.ejpb.2023.07.008.